CXCL13 and synovial sarcoma: This progressive nature of the SS-like disease is further supported by the concomitant upregulated expressions of the Cxcl13 chemokine and its receptor Cxcr5 in the lacrimal and salivary glands that are at their maximum around 16 weeks of age [42,43].